Singapore News

News from Singapore

New alzheimer drug set to begin trials

Posted by jtsmyth8 on December 7, 2007

A trial for a new drug to combat the debilitating brain disease Alzheimer’s has started on patients here, while others for cancer and the degenerative neurological condition Parkinson’s are starting soon. The clinical trials are being done by Japanese pharmaceutical giant Eisai, which has set up a centre in Singapore to coordinate US$50 million (S$72 million) in clinical research annually in the Asia- Pacific and the Middle-East.

Having the centre here means that applying for drug approvals in Singapore and other Asian countries will be faster, said Eisai’s regional medical director, Dr Raymond Chua.

Eisai plans to run half of all its trials in the Asia-Pacific and the Middle-East, up from 10 per cent now.

In Singapore, a trial to study the effects of a new form of Eisai’s drug Aricept on Alzheimer’s has already begun in public hospitals here, including Singapore General Hospital. (story)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

 
%d bloggers like this: